title: Interstitial purine metabolites in hearts with LV remodeling.
abstract: The myocardial ATP concentration is significantly decreased in failing hearts, which may be related to the progressive loss of the myocardial total adenine nucleotide pool. The total myocardial interstitial purine metabolites (IPM) in the dialysate of interstitial fluid could reflect the tissue ATP depletion. In rats, postmyocardial infarction (MI) left ventricular (LV) remodeling was induced by ligation of the coronary artery. Cardiac microdialysis was employed to assess changes of IPM in response to graded beta-adrenergic stimulation with isoproterenol (Iso) in myocardium of hearts with post-MI LV remodeling (MI group) or hearts with sham operation (sham group). The dialysate samples were analyzed for adenosine, inosine, hypoxanthine, xanthine, and uric acid. LV volume was greater in the MI group (2.2 +/- 0.2 ml/kg) compared with the sham group (1.3 +/- 0.2 ml/kg, P < 0.05). Infarct size was 28 +/- 4%. The baseline dialysate level of uric acid was higher in the MI group (18.9 +/- 3.4 micromol) compared with the sham group (4.6 +/- 0.7 micromol, P < 0.01). During and after Iso infusion, the dialysate levels of adenosine, xanthine, and uric acid were all significantly higher in the MI group. Thus the level of IPM is increased in hearts with postinfarction LV remodeling both at baseline and during Iso infusion. These results suggest that the decreased myocardial ATP level in hearts with post-MI LV remodeling may be caused by the chronic depletion of the total adenine nucleotide pool.
authors.affiliation: Research Institute of Cardiology, Minsk, Republic of Belarus.
authors.forename: Andrey V
authors.initials: AV
authors.lastname: Gourine
authors.forename: Qingsong
authors.initials: Q
authors.lastname: Hu
authors.forename: Paul R
authors.initials: PR
authors.lastname: Sander
authors.forename: Aleksandr I
authors.initials: AI
authors.lastname: Kuzmin
authors.forename: Nadia
authors.initials: N
authors.lastname: Hanafy
authors.forename: Svetlana A
authors.initials: SA
authors.lastname: Davydova
authors.forename: Dmitry V
authors.initials: DV
authors.lastname: Zaretsky
authors.forename: Jianyi
authors.initials: J
authors.lastname: Zhang
mesh_terms: D000227:Adenine Nucleotides / Q000378:metabolism*; D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D002302:Cardiac Output / Q000502:physiology; D006339:Heart Rate / Q000502:physiology; D006439:Hemodynamics / Q000502:physiology*; D019271:Hypoxanthine / Q000378:metabolism; D007288:Inosine / Q000378:metabolism; D007545:Isoproterenol / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D017551:Microdialysis; D023421:Models, Animal; D011687:Purines / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D014527:Uric Acid / Q000378:metabolism; D016277:Ventricular Function, Left / Q000187:drug effects / Q000502:physiology*; D020257:Ventricular Remodeling / Q000187:drug effects / Q000502:physiology*; D019820:Xanthine / Q000378:metabolism
chemical_list: D000227:Adenine Nucleotides; D011687:Purines; D019820:Xanthine; D014527:Uric Acid; D019271:Hypoxanthine; D007288:Inosine; D000255:Adenosine Triphosphate; D007545:Isoproterenol